HRH1 and obesity due to melanocortin 4 receptor deficiency: These evidences suggested that potential drug candidates which could regulate the hypothalamic H1R-AMPK signaling, POMC expression and BAT thermogenesis might significantly prevent olanzapine-induced obesity.